venBio Global Strategic Fund II L.P.
Related Filers (16)
- venBio Global Strategic GP II, L.P. (28)
- Adelman Robert J (28)
- venBio Global Strategic GP II, Ltd. (28)
- GOODMAN COREY S (26)
- Akero Therapeutics, Inc. (18)
- Checkmate Pharmaceuticals, Inc. (13)
- Nabriva Therapeutics plc (4)
- Menlo Therapeutics Inc. (4)
- Apellis Pharmaceuticals, Inc. (4)
- IMPEL NEUROPHARMA INC (4)
- ALX ONCOLOGY HOLDINGS INC (3)
- venBio Global Strategic GP, L.P. (2)
- venBio Global Strategic GP, Ltd. (2)
- venBio Global Strategic Fund, L.P. (2)
- Harmony Biosciences Holdings, Inc. (2)
- Verona Pharma plc (1)
- Show More ...
Other (3)
D/A
Thursday, 3/2/2017
Exempt (Private) Offering
D/A
Friday, 3/18/2016
Exempt (Private) Offering
D
Thursday, 3/19/2015
Exempt (Private) Offering
Ownership (52)
SC 13G/A
Tuesday, 6/7/2022
Checkmate Pharmaceuticals, Inc.: Major Shareholders
4
Tuesday, 5/17/2022
Checkmate Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/12/2022
Checkmate Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/9/2022
Checkmate Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 5/5/2022
Checkmate Pharmaceuticals, Inc.: Major Shareholders
4
Wednesday, 5/4/2022
Checkmate Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/29/2022
Checkmate Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/26/2022
Checkmate Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/21/2022
Checkmate Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
Harmony Biosciences Holdings, Inc.: Major Shareholders
SC 13D/A
Friday, 5/7/2021
Akero Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 5/7/2021
IMPEL NEUROPHARMA INC: Major Shareholders
4
Thursday, 4/29/2021
IMPEL NEUROPHARMA INC: Statement of changes in beneficial ownership of securities
4
Monday, 4/26/2021
IMPEL NEUROPHARMA INC: Statement of changes in beneficial ownership of securities
3
Thursday, 4/22/2021
IMPEL NEUROPHARMA INC: Initial statement of beneficial ownership of securities
SC 13G
Tuesday, 2/16/2021
Harmony Biosciences Holdings, Inc.: Major Shareholders
SC 13G
Tuesday, 10/6/2020
Checkmate Pharmaceuticals, Inc.: Major Shareholders
SC 13D
Thursday, 10/1/2020
ALX ONCOLOGY HOLDINGS INC: Major Shareholders
SC 13D/A
Wednesday, 9/9/2020
Akero Therapeutics, Inc.: Major Shareholders
4
Wednesday, 8/12/2020
Checkmate Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/6/2020
Checkmate Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 7/21/2020
ALX ONCOLOGY HOLDINGS INC: Statement of changes in beneficial ownership of securities
3
Thursday, 7/16/2020
ALX ONCOLOGY HOLDINGS INC: Initial statement of beneficial ownership of securities
4
Monday, 7/6/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 4/16/2020
Menlo Therapeutics Inc.: Major Shareholders
4
Friday, 3/6/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/3/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/27/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/12/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/10/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/6/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 1/15/2020
Akero Therapeutics, Inc.: Major Shareholders
4
Tuesday, 1/14/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/10/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/8/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/6/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/3/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Wednesday, 6/26/2019
Akero Therapeutics, Inc.: Major Shareholders
4
Tuesday, 6/25/2019
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/19/2019
Akero Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Thursday, 2/14/2019
Nabriva Therapeutics plc: Major Shareholders
SC 13G/A
Thursday, 2/14/2019
Apellis Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Friday, 2/9/2018
Nabriva Therapeutics plc: Major Shareholders
SC 13G
Friday, 2/9/2018
Apellis Pharmaceuticals, Inc.: Major Shareholders
SC 13D
Thursday, 2/8/2018
Menlo Therapeutics Inc.: Major Shareholders
4
Monday, 1/29/2018
Menlo Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/24/2018
Menlo Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 11/13/2017
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/8/2017
Apellis Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Monday, 5/8/2017
Verona Pharma plc: Major Shareholders
SC 13G/A
Monday, 2/13/2017
Nabriva Therapeutics AG: Major Shareholders
SC 13G
Friday, 4/29/2016
Nabriva Therapeutics AG: Major Shareholders